Rapid screen, complement control cells, panocell, and immucor reagents

Ended Awarded

Contract number
HT001421F0006
Awardee
Awarding agency
Obligated
$20,000

Award facts

Contract value 100% obligated
$20,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Fort Belvoir, VA 22060, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

Immucor Inc. was awarded a firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency (DHA) to provide rapid screen, complement control cells, Panocell, and Immucor reagents. The contract has a potential value of $20,000 and requires delivery to Fort Belvoir, Virginia by November 9, 2021. No set-aside designation was used for this award made under an existing BPA. The reagents will support DHA's medical laboratory testing programs. Immucor will serve as the prime contractor to deliver the requested products and services.

Quick answers

Who was awarded contract HT001421F0006?

HT001421F0006 was awarded to Immucor Inc. by Defense Health Agency (Department of Defense) on November 10, 2020.

How much is contract HT001421F0006 worth?

The government has obligated $20,000 on HT001421F0006.

Is contract HT001421F0006 an order under another contract?

Yes. HT001421F0006 is a BPA call under HT001420A0010, a blanket purchase agreement.

Was contract HT001421F0006 competed?

The extent of competition for HT001421F0006 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award